Spondyloarthropathies
Conference Coverage
ACR: Etanercept during pregnancy doubles the odds of major malformations
Key clinical point: Although etanercept exposure was associated with more than twofold higher odds of major structural defects, there was no...
News
Methotrexate has a role in treating articular manifestations of psoriatic arthritis
Patients with psoriatic arthritis taking methotrexate demonstrated an improvement in peripheral joint disease, skin disease, enthesitis,...
News
More comorbidity with PsA form of spondyloarthritis
Psoriatic arthritis (PsA) plus spondyloarthritis is associated with a significantly increased risk of cardiovascular and metabolic diseases,...
News
Secukinumab cut ankylosing spondylitis symptoms in MEASURE trials
The interleukin 17-A inhibitor secukinumab significantly reduced the signs and symptoms of ankylosing spondylitis in two phase III trials,...
News
Poor response to third anti-TNF agent seen in most psoriatic arthritis patients
Key clinical point: Patients with psoriatic arthritis who don’t respond to or cannot tolerate two different anti-TNF agents are likely to respond...
News
Genetic differences may help predict progression of PsC to PsA
Conference Coverage
EADV: Pursuing ‘clear’ in psoriasis worthwhile, expert says
A Physician Global Assessment of “clear” is worth striving for in psoriasis patients because it represents a clinically important lesser level of...
News
Anti-TNF therapy can continue for IBD patients with skin lesions
News
Steroid use down, biologic use rising in pregnancies of women with rheumatic disease
Key clinical point: Women with lupus and other rheumatic diseases used fewer steroids during pregnancy over a 12-year period, while use of...
News
Psoriasis cohort reveals high arthritis risk
Key clinical point: Incidence of psoriatic arthritis is higher among psoriasis patients than previously estimated.
Conference Coverage
EADV: New long-term data on biologics for pediatric psoriasis ‘encouraging’
The 1- and 5-year outcomes for adalimumab and etanercept in pediatric psoriasis are reassuring.